Science Explorer Interactive view Map
Company · Graz · Austria

Apomedica (Austria)

apomedica.com/atROR OpenAlex
Research works
7
▲ 24% vs 2013–17
Citations
33
4.5 per fractional work
Top-10% rate
26.9%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: Apomedica (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.09× its world share, 1 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 15.37× its world share, 0 worksPharmacology, Toxico…Materials Science: 1.55× its world share, 0 worksMaterials ScienceHealth Professions: 0.63× its world share, 0 worksHealth ProfessionsMedicine: 2.30× its world share, 1 worksMedicineArts and Humanities: 3.75× its world share, 0 worksArts and Humanities1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 15.4×. Every wedge is a field page.

Which research topics does Apomedica (Austria) publish most on?

By volume in 2022–2025: Natural product bioactivities and synthesis, Curcumin's Biomedical Applications, Chemotherapy-induced cardiotoxicity and mitigation and Paleopathology and ancient diseases.

Natural product bioactiv…0Natural product bioactivities and synthesis: 0 fractional worksCurcumin's Biomedical Ap…0Curcumin's Biomedical Applications: 0 fractional worksChemotherapy-induced cardiotoxicity and mitigation: 0 fractional worksPaleopathology and ancient diseases: 0 fractional worksPeriodontal Regeneration…0Periodontal Regeneration and Treatments: 0 fractional worksCardiac Ischemia and Reperfusion: 0 fractional worksKnee injuries and reconstruction techniques: 0 fractional worksPharmacological Effects …0Pharmacological Effects of Medicinal Plants: 0 fractional worksProteoglycans and glycosaminoglycans research: 0 fractional worksCultural Heritage Materials Analysis: 0 fractional works
Molecular BiologyMolecular MedicineCardiology and Cardiovascular MedicineArcheology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Natural product bioactivities and synthesis Molecular Biology 0 works
  2. 2 Curcumin's Biomedical Applications Molecular Medicine 0 works
  3. 3 Chemotherapy-induced cardiotoxicity and mitigation Cardiology and Cardiovascular Medicine 0 works
  4. 4 Paleopathology and ancient diseases Archeology 0 works
  5. 5 Periodontal Regeneration and Treatments Urology 0 works
  6. 6 Cardiac Ischemia and Reperfusion Pathology and Forensic Medicine 0 works
  7. 7 Knee injuries and reconstruction techniques Surgery 0 works
  8. 8 Pharmacological Effects of Medicinal Plants Pharmacology 0 works
  9. 9 Proteoglycans and glycosaminoglycans research Cell Biology 0 works
  10. 10 Cultural Heritage Materials Analysis Archeology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.1%not open46.9%

World: 28% of research is openly available.

with international co-authors38.2%domestic only61.8%

World: 19% is written across borders.

How has Apomedica (Austria)'s research output changed?

Output in 2018–2022 was 24% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Graz

All research institutions in Graz

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.